Doctor Care Anywhere Group Plc (doc) Logo

Doctor Care Anywhere Group Plc (DOC)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

DOC Chart

DOC's Principal Activity is the digital healthcare service and development.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -29.93%

Size

Market Capitalisation
ASX Rank 826 of 2,295
Sector Rank

Key Information

Shares Issued
Sector Healthcare
Similar Companies -
EPS $0.00
DPS $0.00
NTA per share $0.00

Broker Consensus

DOC is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

Doctor Care Anywhere Group PLC (DOC) is a UK-based telehealth company that is committed to delivering high-quality, effective and efficient care to its patients, whilst reducing the overall cost of providing clinical services. DOC utilises its relationships with health insurers, healthcare providers and corporate customers to connect with patients and deliver a range of telehealth services.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office London United Kingdom EC4Y 8DP
Website www.doctorcareanywhere.com
Registry Computershare
Auditor Grant Thornton UK LLP
Date Listed 4 Dec 2020

Upcoming Calendar (Forecasted)

Date Event
24/02/2022 Report (Prelim)
30/03/2022 Report (Annual)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Daniel (Dan) Curran Chief Financial Officer,Company Secretary Jan 2021
Mr Simon Calver Non-Executive Director Oct 2020 Director Bio icon

Mr Simon Calver

Non-Executive Director

Mr Calver has experience leading fast-growing technology businesses. Simon is an experienced non-executive board director, investor in technology, chief executive and entrepreneur. Simon has won recognition for his work at LoveFilm and with Entrepreneurs through the UK. As well as EY's Entrepreneur of the Year, he won the Sunday Times Buyout Track for PE backed businesses and the Confederation British Industries (CBI) Growth Company of the Year. Previous roles include being Chairman of technology start-up companies Moo Print Limited and Chemist Direct Limited, recipe box subscription company Gousto Ltd, Firefly Learning Ltd and UK Business Angels Association, Non-Executive Director of Global App Testing and Datalex PLC and CEO of Mothercare PLC and LoveFilm International until its sale to Amazon in 2011. In 2015, Simon set up BGF Ventures, a 200 million venture fund and substantial shareholder of Doctor Care Anywhere. Prior to this, Simon worked for large blue-chip companies such as Unilever, Pepsi and Dell. Simon speaks regularly on corporate change, leadership and disruptive business models.

Mr Richard John Dammery Non-Executive Director Sep 2020 Director Bio icon

Mr Richard John Dammery

Non-Executive Director

Mr Dammery has board and governance experience, having served on and advised a range of boards over the past 25 years. Before commencing his non-executive career, Richard held senior leadership roles in a range of major Australian and New Zealand companies, including Woolworths Group where he was the Chief Legal Officer and Company Secretary, responsible for legal and regulatory advice, group governance and group compliance. Prior to this, Richard held a number of commercial general management roles, principally in the telecommunications and technology sectors. From 2008-2014 Richard was a partner of leading law firm, Minter Ellison, specialising in corporate advice and mergers and acquisitions. Richard currently serves on the boards of Nexus Hospitals Group, Aussie Broadband Limited and Creative Partnerships Australia. He is an Adjunct Professor (Practice) and Industry Fellow at Monash Business School. He is chairman of Risk Management Committee.

Dr Leanne Rowe Non-Executive Director Sep 2020 Director Bio icon

Dr Leanne Rowe

Non-Executive Director

Dr Rowe has a understanding of clinical governance and medico-legal issues. Leanne's current roles include Chairman of Nexus Hospitals, and Non-Executive Director of Japara Healthcare Limited, the Medical Indemnity Protection Society (MIPS) and MIPS Insurance in Australia. She is a Presiding Member at Victorian Medical Panels which involves chairing panels of medical and surgical specialists to consider complex cases of patient injury. Leanne has a Professorial appointment at Monash University, and she has published 10 health-related books. Her most recent book 'Every doctor: healthier doctors = healthier patients' was published internationally by CRC Press (UK). Previous roles include being a Non-Executive Director of three Australian private health insurers including Medibank Private Limited (prior to its ASX listing), Australian Health Management and GMHBA Limited. She has also served on the boards of I-MED Radiology Network Pty Ltd, the largest private radiology provider in Australia; Beyondblue, the national depression initiative; and Barwon Health, the largest regional hospital and health network in Victoria, Australia. She was Chairman of the Royal Australian College of General Practitioners National Council and Victorian board. Leanne's clinical leadership has been recognised in Australia by an Order of Australia for service to medicine, 'The Rose Hunt Medal' and 'The College Medal' by the Royal Australian College of General Practitioners, and 'Best Individual Contribution to Health Care' by the Australian Medical Association. She is member of Risk Management Committee.

Ms Vanessa Miscamble Wallace Non-Executive Director Sep 2020 Director Bio icon

Ms Vanessa Miscamble Wallace

Non-Executive Director

Ms Wallace is an experienced board director, strategy management consultant, investor and founder in innovative, early-stage and digital companies. This includes being Chair of AMP Capital Ltd (from 2016 to 2018) and Drop Bio Pty Ltd (from 2018 to present) and Managing Director of Miscamble Forrest Pty Ltd as well as being a non-executive director of Global Board of Booz & Company (2006-2010), Wesfarmers Ltd (2010-present) and SEEK Ltd (2017-present). Vanessa spent more than 25 years at Booz & Company as a Senior Partner and Executive Chairman in Japan, and a Director of several Asian entities of the business. She led the Financial Services Practice in global markets and the strategy practice in Australia. She has extensive experience in post-merger integration, risk management and supporting leadership teams with their strategies and operational delivery. In the health care sector, Vanessa spent years as a consultant supporting providers across Australia and has been an investor in disruptive, innovative health care business for the last 15 years. More recently, Vanessa has worked with global life and health insurers and early stage ventures building data analytic capabilities and integrating biotechnology and data to define new health care solutions. She is also currently undertaking the MIT Engineering School's Professional Certificate Program in Machine Learning & Artificial Intelligence. Vanessa is a Member of the UNSW Business School Advisory Council and a Member of the Australian Chamber Orchestra Chairman's Council. She is member of Risk Management Committee.

Ms Romana Abdin Non-Executive Director Sep 2020 Director Bio icon

Ms Romana Abdin

Non-Executive Director

Ms Abdin has led the restructuring and investment in digital capability to meet the demands of today's customers, employers and healthcare practitioners, developing new propositions, establishing new relationships, developing people capabilities and a leadership team which has shifted the culture from risk averse and analogue to more customer-centric, agile and engaged. Romana has a industry profile in the UK and has gained extensive commercial, board, governance and regulatory experience in previous roles at Simplyhealth Group, Lloyds Banking Group and Bradford & Bingley Building Society. Romana started her career as a Barrister in London specialising in corporate and commercial law and went on to hold several corporate affairs and legal roles, principally in the financial services and entertainment sectors. She is member of Risk Management Committee.

Mr Jonathan Baines Executive Chairman,Executive Director Nov 2018 Director Bio icon

Mr Jonathan Baines

Executive Chairman,Executive Director

Mr Baines has board and governance experience in the UK, having previously served on and advised both public and private company boards. Jonathan has also previously advised the UK Financial Services Authority (forerunner to the Prudential Regulatory Authority) on matters related to governance and succession planning. Prior to this, Jonathan spent 12 years in the British Army before joining and subsequently managing the UK Treasury division of Brown Shipley PLC. He spent 26 years in the executive search industry, starting his own company in 1986 which he sold to Whitehead Mann PLC, where he led the financial services practice before becoming Chairman in 2005. From 2005 to 2014, he served as Chairman of Korn Ferry Inc in Europe, the Middle East and Africa (EMEA) where he was involved in Chair and CEO succession planning at a number of the largest global financial services companies, including one of the leading banks in Australia. Since leaving the search industry in 2014, Jonathan has continued to advise and work closely with Citigroup in EMEA on client activities, as a Senior Adviser at Tulchan Communications, and as Chairman of Candy Kittens, a private and rapidly growing confectionery business.

Mr David Ravech Non-Executive Director Apr 2015 Director Bio icon

Mr David Ravech

Non-Executive Director

Mr Ravech has led and invested in disruptive technology companies for more than 20 years. Prior to his involvement with Doctor Care Anywhere, David was the founder and CEO of Overland Health (now part of Slater and Gordon Solutions), a technologydriven provider of rehabilitation services. He also founded and was later Co-CEO of Global Freight Exchange which provided the world's leading airlines and freight forwarders with the first online price and availability comparison engine and transaction system for airfreight (with the company being sold in 2007 to Descartes (Nasdaq: DSGX), a provider of cloudbased logistics and supply chain management solutions). He then spent six years as a strategy management consultant at McKinsey, based in the Melbourne and London offices. He has worked in Australia, the UK, Japan, Israel and several European countries, primarily serving clients in the retail, brewing, telecoms and banking sectors with a focus on mergers and acquisitions, competition law approvals and pricing strategy.

Dr Bayju Thakar Chief Executive Officer,Executive Director Feb 2014 Director Bio icon

Dr Bayju Thakar

Chief Executive Officer,Executive Director

Dr Thakar has been responsible for leading the Company's growth from inception through to a vertically integrated digital health provider, serving some of the largest blue-chip health insurers and hospital groups in the world.

Kate Bunyan Chief Medical Officer N/A
Ben Kent Chief Operating and Financial Officer N/A

Director Interests

The current holdings of DOC directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Bayju Thakar 31/12/2020 12,668,969 N/A 13,325,818 N/A
David Ravech 31/12/2020 N/A 44,264,604 N/A N/A
Simon Calver 31/12/2020 82,188 N/A N/A N/A
Romana Abdin 31/12/2020 25,000 N/A N/A N/A
Jonathan Baines 31/12/2020 N/A 100,000 4,470,970 N/A
Vanessa Wallace 31/12/2020 162,500 N/A N/A N/A
Leanne Rowe 31/12/2020 N/A 137,500 N/A N/A
Richard Dammery 31/12/2020 N/A 82,188 N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Dec 31, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Carani Holdings Limited 44,264,604 13.90%
National Nominees Limited 32,592,870 10.23%
Vijay Patel 26,094,880 8.19%
HSBC Custody Nominees (Australia) Limited 20,055,115 6.30%
BGF Nominees Limited <BGF Investments LP A/C> 18,042,248 5.66%
UBS Nominees Pty Ltd 17,687,081 5.55%
Citicorp Nominees Pty Limited 16,255,023 5.10%
Bayju Ashvin Thakar 12,668,969 3.98%
Patagorang Pty Limited 11,245,121 3.53%
CS Third Nominees Pty Limited <HSBC Cust Nom Au Ltd 13 A/C> 9,091,199 2.85%
Bhikhu Patel 8,698,178 2.73%
Hadston 1 LLP 8,587,773 2.70%
Morgan Stanley Australia Securities (Nominee) Pty Limited <No 1 Account> 7,200,000 2.26%
Tiga Trading Pty Ltd 6,247,560 1.96%
Carjay Investments Pty Ltd 4,881,750 1.53%
Xilan Capital Limited 3,949,773 1.24%
BGF Nominees Limited <BGF Ventures LP A/C> 3,742,855 1.17%
BNP Paribas Noms Pty Ltd <Drp> 3,265,218 1.03%
HSBC Custody Nominees (Australia) Limited A/C 2 3,075,598 0.97%
Barnett Waddingham Trustees (1996) Limited <Anthony Banks Ltd P/P A/C> 2,406,855 0.76%
Barnett Waddingham Trustees (1996) Limited <HRMP Directors P/Sch A/C> 2,406,855 0.76%
Barnett Waddingham Trustees (1996) Limited <Mj Rutherford Ltd D/Pf A/C> 2,406,855 0.76%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 13 105 275 832 86 1,311

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Carani Holdings Limited 31/12/2020 44,264,604 13.90
BGF Nominees Limited 31/12/2020 21,785,103 6.84
Vijay Patel 31/12/2020 37,133,058 11.68
Caledonia (Private) Investments Pty Limited 31/12/2020 30,084,000 9.45
Perennial Value Management Limited 21/06/2021 33,922,801 10.64

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
21-06-21 Perennial Value Management Limited 3,213,678 9.63 10.64
26-04-21 Perennial Value Management Limited 7,367,391 7.32 9.63
25-03-21 Perennial Value Management Limited 5,328,951 5.65 7.32
03-03-21 Perennial Value Management Limited 18,012,781 -- 5.65
04-12-20 BGF Nominees Limited 21,785,103 -- 6.84
04-12-20 Bhikhu Patel 37,133,058 -- 11.68
04-12-20 Carani Holdings Limited 44,264,604 -- 13.90
04-12-20 Vijay Patel 37,133,058 -- 11.66
04-12-20 Mark Cotterill 37,133,058 -- 11.66
04-12-20 Amit Patel 37,133,058 -- 11.66
04-12-20 Perennial Value Management Limited 16,246,338 -- 5.10
04-12-20 Caledonia (Private) Investments Pty Limited 30,084,000 -- 9.45

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
12-02-21 Perennial Value Management Limited 16,246,338 5.10 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
DOC Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.